HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets
Article in Cancers (November 2023)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells
Article in Blood (September 2023)
c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway
Article in Biomedicines (October 2022)